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Appropriateness of antibiotic prescribing for upper respiratory tract infections
in general practice: Comparison between Denmark and Iceland
Nanna Ru´n Sigurardo´ttira, Anni Brit Sternhagen Nielsena, Anders Munckb and Lars Bjerruma
aSection and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; bAudit
Project Odense, Research Unit of General Practice, University of Southern Denmark, Odense, Denmark
ABSTRACT
Objective: To compare the appropriateness of antibiotic prescribing for upper respiratory tract
infections (URTIs) in two countries with different prevalence of antimicrobial resistance: Denmark
and Iceland.
Design: A cross-sectional study. Settings and subjects. General practitioners (GPs) in Denmark
(n¼ 78) and Iceland (n¼ 21) registered all patients with URTI according to the Audit Project Odense
(APO) method during a three-week period in the winter months of 2008 and 2009.
Main outcome measures: Appropriateness of antibiotic prescribing in patients with URTI in Denmark
and Iceland.
Results: A total of 1428 patients were registered (Denmark: n¼ 1208; Iceland: n¼ 220). A majority of
patients in both countries were prescribed antibiotics, and only a minority of the prescriptions
could be classified as appropriate prescribing. In general, Icelandic GPs more often prescribed
antibiotics (Iceland¼ 75.8% vs. Denmark¼ 59.3%), but Danish GPs had a higher percentage of
inappropriate antibiotic prescribing for sinusitis, and Icelandic GPs for pharyngotonsillitis. No
differences were found for acute otitis media (AOM). The different antibiotic prescribing patterns
between Denmark and Iceland could not fully be explained by different symptoms and signs
among patients.
Conclusion: Icelandic GPs have a higher antibiotic prescribing rate compared with Danish GPs, but
the percentage of inappropriate antibiotic prescribing is highest in Denmark for sinusitis, and in
Iceland for pharyngotonsillitis.
KEY POINTS
 Within the Nordic countries there are marked differences in antimicrobial resistance and
antibiotic use.
 Iceland differs from Denmark by a higher antibiotic prescribing rate and a higher prevalence of
antimicrobial resistance.
 The majority of antibiotics are prescribed in primary care and most often for upper respiratory
infections (URTIs).
 Only a minor amount of antibiotic prescriptions for URTIs can be classified as appropriate;
inappropriate antibiotic prescribing is higher in Denmark than in Iceland for sinusitis and the
opposite for pharyngotonsillitis.
 The different antibiotic prescribing patterns between Denmark and Iceland cannot be fully
explained by different clinical criteria among patients.
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Background
Antimicrobial resistance is an increasing problem world-
wide [1,2], causing increased morbidity and mortality [3].
Inappropriate consumption of antibiotics is one of the
most important reasons for the development of anti-
microbial resistance [2].
Antimicrobial resistance varies between the European
countries: the highest prevalence is found in the
Southern and Eastern European countries, while a
lower prevalence is seen in the Northern European
countries [4,5]. However, since 2004 the prevalence
of antimicrobial resistance has been up to five times
higher in Iceland than in Denmark [4,6]. This difference
may reflect variation in the use of antibiotics:
Between 2004 and 2008 Iceland had the highest
consumption of antibiotics in the Nordic countries with
a number of defined daily doses per 1000 inhabitants
per day (DID) in the range of 21.6–23.4, whereas the use
of antibiotics in Denmark at the same time was 15.2–16.7
DID [7–9].
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The majority of antibiotics are prescribed in general
practice, and about two-thirds of all prescriptions are for
respiratory tract infections (RTI). However, the majority
of RTIs in general practice are harmless and self-limiting
[10–12]. Even when the aetiology is bacterial, the
duration and severity of symptoms are only slightly
influenced by the use of antibiotics, particular in patients
with upper respiratory tract infections (URTIs) [12,13].
General practitioners’ (GPs’) antibiotic prescribing
pattern differs considerably for RTIs [14–16]. In general
practice, the decision to prescribe antibiotics for URTIs is
mainly based on the presence of signs and symptoms.
There is a lack of simple and accurate microbiological
tests that can help the GP to make the right decision
concerning antibiotic prescribing [16]. Uncertainty and
doubt regarding microbiological aetiology may increase
the influence of patient demand and other non-clinical
factors leading to an increased risk of inappropriate
antibiotic prescribing
In order to explore potential differences in the
appropriateness of antibiotic prescribing between
Iceland and Denmark more knowledge is needed
concerning the diagnoses and clinical criteria for anti-
biotic prescribing, i.e. the symptoms and signs behind
the doctor’s decision to prescribe.
The aim of this study was to compare the appropri-
ateness of antibiotic prescribing for URTI in two
countries with a different prevalence of antimicrobial
resistance: Denmark and Iceland.
Material and methods
Data for this cross-sectional study were based on
comparable data from Danish and Icelandic GPs
participating in audits according to the Audit Project
Odense (APO) method [17]. The Danish data came from
of the EU-funded project ‘‘Health Alliance for Prudent
Prescribing, Yield And Use of antimicrobial Drugs In the
Treatment of respiratory tract infections’’ (HAPPY AUDIT)
[18] and the Icelandic data from a Nordic audit using
exactly the same methodology as HAPPY AUDIT. In both
audits, GPs were invited by email or personal contact. A
total of 21 Icelandic GPs (10.3% of all Icelandic GPs) and
78 Danish GPs (2.2% of all Danish GPs) volunteered to
participate.
Population
A total of 1428 patients with URTI were registered in
Denmark (n¼ 1208) and Iceland (n¼ 220).
We included patients with URTIs that were diagnosed
according to the International Classification of Primary
Care: acute otitis media (H71, H72), acute sinusitis (R75)
and acute pharyngotonsillitis (R72, R74, R76) [19]. Only
patients consulting their GP for the first time for the
current infection were included. Telephone consult-
ations, home visits, and patients receiving antibiotics
prior to the consultation were excluded.
Data collection
Within a three-week period in the winter months of 2008
(Denmark) and of 2009 (Iceland), GPs prospectively
registered patients suspected of RTIs. For each patient
the GP registered age, sex, symptoms and signs,
duration of symptoms (days), diagnostic tests per-
formed, e.g. Streptococcus antigen test (Strep-A) or a
C-reactive protein (CRP), assumed microbiological aeti-
ology (virus or bacteria), assumed diagnosis, antibiotic
treatment and allergy to penicillin, patient demand for
antibiotics, and referral to hospital. The registration chart
used in Iceland was translated into Icelandic and back
translated to Danish in order to ensure an equal
understanding and interpretation of all variables regis-
tered in the two countries. See detailed information
about the HAPPY AUDIT method in the study protocol,
published in BMC Family Practice [18].
Criteria for appropriateness of antibiotic
prescriptions
Antibiotic prescriptions following international recom-
mendations for antibiotic prescribing in patients with
URTIs (HAPPY AUDIT, EPOS) [20,21] were classified as
appropriate prescribing. Prescriptions not fulfilling inter-
national criteria for treatment with antibiotics were
classified as inappropriate prescribing. Prescriptions
fulfilling only some of the agreed criteria for antibiotic
prescribing were classified as possibly appropriate
prescribing [20–22]. Table 1 gives the criteria used to
classify appropriate and inappropriate antibiotic
prescribing.
Statistical analyses
Data are presented as proportions. Comparisons
between the countries were performed by using the
Wilcoxon test for continuous variables and chi-square
tests for categorical variables. In all analyses we con-
sidered a p-value of50.05 as statistically significant. The
data were analysed in the Statistical Analysis Software
(SAS) (SAS Institute Inc., Cary, IN, USA) version 9.2 and
Microsoft Office Excel 2007 (Microsoft Corp., Redmond,
WA, USA).
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Results
A total of 1428 patients with acute otitis media, acute
sinusitis, and acute pharyngotonsillitis were included in
the study (Denmark¼ 1208 and Iceland¼ 220). Acute
pharyngotonsillitis was most frequent in Denmark, while
acute sinusitis and acute otitis media were more
frequent in Iceland (Table II). No significant differences
were found for age and sex distribution.
In both countries, the majority of patients with URTI were
prescribed antibiotics (Denmark¼ 59.3%, Iceland¼ 75.8%).
Considerable variations in antibiotic prescribing rates
were found (Table III). The highest antibiotic prescribing
rate was found in patients with suspected acute sinusitis
(Iceland¼ 98.6%, Denmark¼ 75.5%), and the lowest
prescribing rate in patients with acute pharyngotonsillitis
(Iceland¼ 58.7%, Denmark¼ 46.3%).
The appropriateness of antibiotic prescribing for the
different types of URTI is shown in Figure 1. In patients
with acute sinusitis the percentage of inappropriate
antibiotic prescribing was higher in Denmark than in
Iceland (16.4% vs. 4.1%, p50.0001), and for acute otitis
media the corresponding figures were 19.7% and 8.3%
(p40.05). In patients with acute pharyngotonsillitis we
found a higher percentage of inappropriate antibiotics in
Iceland compared with Denmark (14.7% vs. 5.7%,
p¼ 0.003).
For all types of URTI the median duration of symp-
toms before GP contact was higher in Iceland than in
Denmark (see Table III). For acute sinusitis more than
90% of Icelandic patients compared with 60% of Danish
patients had symptoms45 days before they contacted a
GP. A greater proportion of patients with acute otitis
media in Denmark than in Iceland had fever (53.2% vs.
38.9%), but no difference was found in the occurrence of
purulent ear secretion. In both countries more than 50%
of patients with suspected acute pharyngotonsillitis
fulfilled two or more Centor criteria. However, no
significant difference was found in the distribution of
Centor criteria between Denmark and Iceland.
A higher proportion of GPs in Denmark than Iceland
used CRP (58.5% vs. 2.7%) and Strep-A test (83.5% vs.
66.7%).
Discussion
Our results showed that antibiotic prescribing for
URTI was high in both countries. Only a minority
of all antibiotic prescriptions could be classified as
Table 1. Criteria for classification of appropriate and inappropriate antibiotic prescribing in patients with upper respiratory tract
infections.
Appropriate antibiotic prescribing Inappropriate antibiotic prescribing
Acute sinusitis [20,21] Duration of symptoms45 days AND fever Duration of symptoms 5 days AND no fever
Acute otitis media [20,22] Duration of symptoms 43 days AND purulent ear
secretion OR age52 years
Duration of symptoms 3 days AND no purulent ear
secretion
Acute pharyngotonsillitis [20,22] Fulfil 2 Centor criteria AND a positive Strep-A test OR
Fulfil 4 Centor criteria
Fulfil52 Centor criteria OR a negative Strep-A test
Notes: 1Patients 5 years of age, suspected of acute pharyngotonsillitis. 2The Centor criteria include: fever438.5c, tonsillar exudates, tender anterior cervical
adenopathy, and absence of cough.
Table 2. Number and characteristics of patients with upper
respiratory tract infections in Iceland and Denmark.
Iceland
(n¼ 220)
Denmark
(n¼ 1208) p-value
Males (%) 106 (48.2) 505 (41.8) 0.08
Median age (years) (IQR1) 25 (6-42) 23 (7-40) 0.91
Acute otitis media (%) 72 (32.7) 286 (23.7) 50.005
Acute pharyngotonsillitis (%) 75 (34.1) 650 (53.8) 50.0001
Acute sinusitis (%) 73 (33.2) 272 (22.5) 50.005
Antibiotic prescribing2 (%) 166 (75.8) 712 (59.3) 50.0001
Notes: 1IQR¼ interquartile range. 2Nine missing values (Iceland¼ 1,
Denmark¼ 8).
Table 3. Distribution of symptoms and signs and antibiotic
prescribing in patients with upper respiratory tract infections in
Iceland and Denmark.
Iceland Denmark p-value
Acute otitis media, no. (%) 72 (32.7) 286 (23.7) 50.05
Males, no. (%) 44 (61.1) 139 (47.6) 0.06
Median age, years (IQR) 3 (1–8) 3 (1–7) 0.92
Duration of symptoms,
median days, (IQR)
4 (2–7) 3 (2–5) 50.01
Fever1 no. (%) 28 (38.9) 152 (53.2) 50.05
Purulent ear secretion no. (%) 18 (25.0) 69 (24.1) 0.88
Antibiotic prescribing no. (%) 50 (70.4) 210 (73.7) 0.58
Pharyngotonsillitis, no. (%) 75 (34.1) 650 (53.8) 50.0001
Males, no. (%) 35 (46.7) 281 (43.2) 0.57
Age, median years (IQR) 28 (18–41) 24 (12–38) 50.05
Duration of symptoms,
median days (IQR)
4 (3–6) 3 (2–5) 50.05
No. of patients (%) with 2
Centor criteria
41 (54.7) 336 (51.7) 0.63
No of patients (%) with a Strep-A2
test performed
50 (66.7) 543 (83.5) 50.05
Antibiotics prescribed, no. (%) 44 (58.7) 299 (46.3) 50.05
Sinusitis, no. (%) 73 (33.2) 272 (22.5) 50.05
Males, no. (%) 27 (37.0) 85 (31.3) 0.35
Median age, years (IQR) 39 (27–55) 41 (32–55) 0.41
Duration of symptoms,
median days (IQR)
11 (8–20) 7 (4–12) 50.0001
Fever, no. (%) 17 (23.3) 83 (30.5) 0.23
No. of patients (%) with
CRP3 performed
2 (2.7) 159 (58.5) 50.0001
Antibiotics prescribed, no. (%) 72 (98.6) 203 (75.5) 50.0001
Notes: 1Fever¼438.5c. 2Rapid Streptococcus A antigen detection test.
3C-reactive protein measurement.
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appropriate. In general, Icelandic GPs showed the
highest antibiotic prescribing rate. However, in patients
with sinusitis, Danish GPs had the highest proportion of
inappropriate antibiotic prescribing and in patients with
pharyngotonsillitis the highest proportion of inappro-
priate prescribing was found among Icelandic GPs. We
found no significant difference in appropriate prescrib-
ing in patients with AOM. Several studies have shown
that the majority of URTIs are caused by a virus, and
most antibiotic treatments for URTI are therefore not
associated with any benefit. On the contrary, overuse of
antibiotics may increase the risk of adverse effects and
enhance the risk of antibiotic resistance.
Weaknesses and strengths
GPs participated on a voluntary basis and this may have
introduced a selection bias; prescribing habits may not
represent the average antibiotic prescribing in the two
countries. Furthermore, participating GPs may be more
interested in rational antibiotic treatment than GPs in
general. Our results may therefore be an underestimate
of potential overprescribing of antibiotics. Second, all
data were self-reported by the GPs, and we are thereby
not able to explore the accuracy of the diagnoses or the
symptoms reported.
It is a strength that we used exactly the same method
to register patients with URTI in Denmark and Iceland.
The APO audit method is primarily a quality improve-
ment method that measures performance on two
occasions, before and after an intervention. Data from
both countries came from the first registration, i.e.
before intervention, and therefore reflect the quality of
antibiotic prescribing among GPs who were not exposed
to any intervention. Neither of the two countries had
official national guidelines for diagnosis and treatment
of URTI during the study period. According to national
statistics, overall prescribing of antibiotics in Iceland
reduced slightly from 2008 to 2009, but we do not
believe that the quality of antibiotic prescribing by
Icelandic GPs changed markedly between 2008 and 2009
[7]. Since there were no official guidelines for diagnosis
and treatment of URTI during the study period we do
not believe that difference in data collection year, 2008
and 2009, respectively, has had an impact on the results
in our study.
It is a limitation that GPs had only a short time to
register characteristics of patients during the consult-
ation and only the most typical signs and symptoms of
RTIs according to the medical literature were recorded.
The sample of patients from Iceland was small compared
with the Danish sample size. This reflects, to some
extent, the fact that Iceland is a small country compared
with Denmark. If we look at the percentage of
participating patients in relation to the country popula-
tion it was more than three times higher in Iceland
(0.07%) than in Denmark (0.02%). The participating GPs
in Iceland represented more than 10% of all GPs in the
country and, in spite of the limited absolute numbers of
GPs and patients involved in Iceland, we believe that our
data represent a true picture of the antibiotic prescribing
pattern in both countries.
Most patients with URTI are diagnosed in general
practice, but there is no general agreement regarding
the specific diagnostic criteria to be used, and this may
have induced a risk of diagnostic misclassification. Often,
GPs’ decisions concerning diagnosis and treatment are
made simultaneously, or the prescribing decision may
even be taken before a clear diagnosis is established.
The antibiotic prescribing may therefore have influenced
the GP’s choice of diagnosis in order to fit the decision
regarding treatment. In both countries, a substantial
number of antibiotic prescriptions were classified as
possible appropriate prescriptions and, for all types of
URTI, the percentages of possible appropriate prescrip-
tions were highest in Iceland. Possible appropriate
prescribing thus represents a large ‘‘grey zone’’ in both
countries. The potential uncertainty regarding how to
interpret possible appropriate prescriptions may have
induced a misclassification bias. If a higher number of
possible appropriate prescriptions from Iceland were in
reality inappropriate it might have changed our conclu-
sion. Due to the potential uncertainty concerning
16.4 17.8
26.3 21.3
30.8 34.7
42.8
76.7
14.2 22.7
23.1
26.4
16.4
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5.7
14.7
19.7 8.3
0
10
20
30
40
50
60
70
80
90
100
DK IS DK IS DK IS
%
Inappropriate prescribing
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Figure 1. Appropriateness of antibiotic prescribing in patients
with upper respiratory tract infections in Iceland (IS) and
Denmark (DK).
Note: The bars show the proportion of patients prescribed
antibiotics.
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interpretation of possible appropriate prescribing we
compared only inappropriate antibiotic prescriptions in
the two countries.
Finally, the study is cross-sectional and any causal
interpretation should be made with caution.
One of the strengths of our study is that our results
are based on a pragmatic study design reflecting the
presentation and daily management of patients with
URTI in general practice. Therefore, it is most likely that
our results reflect symptoms and signs among patients
in the two countries included. Furthermore, our classi-
fication of antibiotic prescribing as appropriate, inappro-
priate, and possibly appropriate was based on widely
accepted and approved international recommendations
and guidelines [20–22].
Comparison between Denmark and Iceland
Our results showed that inappropriate antibiotic pre-
scribing was higher in Denmark than in Iceland for
sinusitis and the opposite for pharyngotonsillitis and no
significant differences were found for AOM. The larger
proportion of inappropriate antibiotic prescribing in
Denmark than in Iceland for acute sinusitis may partially
be explained by the fact that over 90% of the Icelandic
patients had a symptom duration of 45 days, as
compared with two-thirds of the Danish patients.
According to international guidelines, appropriate pre-
scribing of antibiotics in patients with acute sinusitis
implies that the duration of symptoms is45 days and
fever should be present [21,22].
In Denmark, CRP is recommended in patients with
suspected sinusitis to help the GP make the right
decision regarding antibiotic prescribing. In Iceland,
however, CRP testing was practically not performed.
CRP testing has been shown to reduce antibiotic
overprescribing in patients with acute sinusitis [23,24],
and it is therefore surprising that the percentage of
inappropriate antibiotic prescribing was higher in
Denmark than in Iceland. One reason for this may be
that Danish GPs rely more on the CRP test result instead
of using clinical criteria (e.g. duration of symptoms)
when making a decision as to antibiotic treatment
[20,21].
For acute pharyngotonsillitis the inappropriate pre-
scribing was more pronounced in Iceland than in
Denmark. An equal proportion of patients with acute
pharyngotonsillitis in Iceland and Denmark fulfilled two
or more Centor criteria, but the Icelandic GPs less often
used the Strep-A testing compared with their Danish
colleagues. This is in agreement with studies that have
shown that implementation of Strep-A testing in primary
care may lead to a reduction in antibiotic overprescrib-
ing [13].
Implications for clinicians and future research
Iceland and Denmark, both Nordic countries, have
partially the same historical background and the cultural
and social factors are very similar. It is therefore relevant
to explore the factors behind the difference in antibiotic
prescribing rates in these two countries. By understand-
ing the difference in the prescribing pattern it may be
easier to improve prescribing habits and reduce over-
prescribing. In this study we focused on URTI because
most infections are due to a virus, and the majority of
patients do not benefit from antibiotic treatment. Other
studies have identified patient demand as the most
important non-clinical factor for antibiotic overprescrib-
ing in general practice [25,26]. We did not examine
patient expectation, since this was not within the scope
of the present study.
Generally, GPs in Iceland showed a higher total
prescribing of antibiotics but, interestingly, GPs in
Denmark had the highest rate of inappropriate antibiotic
prescribing for sinusitis, i.e. prescriptions where patients
did not fulfil the clinical criteria for antibiotic treatment.
The difference in prescribing pattern in Iceland and
Denmark can only partially be explained by clinical
symptoms and signs, and other factors known to
influence the GP’s decision should be addressed in
future research.
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